Cited by 62Adrenal and Paraganglionic TumorsRenal cell carcinoma treatmentHepatocellular Carcinoma Treatment and Prognosis

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma

Open access

Abstract

Background Adrenocortical carcinoma (ACC) is a rare disease without effective chemotherapy treated most appropriately with resection. The aim of this study was to evaluate our experience with liver resection for metastatic ACC.Methods This study is a retrospective review of patients who underwent liver resection or radiofrequency ablation (RFA) for ACC from 1979 to 2009.Results A total of 27 patients were identified. Of the 27, 19 underwent liver resection. Of the 19, 10 had a single liver lesion, and 18 of 19 were rendered free of disease in the liver, although only 11 of 19 were rendered completely free of disease because of extrahepatic disease (EHD). Of the 19, 13 had synchronous EHD. Also, 6 of 17 remained disease free in the liver at a median follow-up of 6.2 years (status of 2 of 19 was unknown). Of the 27 patients, 8 underwent RFA, 7 of 8 became free of disease in the liver, and 5 of 7 had EHD. No patients responded to prior chemotherapy. Median overall survival and survival of patients who underwent liver resection or RFA were both 1.9 years (0.2-12 + years); 5-year actuarial survivals were 29% and 29%, respectively. Disease-free interval (DFI) greater than 9 months from primary resection was associated with longer survival (median 4.1 vs 0.9 years; P = .013).Conclusions This study is a tertiary institution series of liver resection and RFA for ACC. Given the lack of effective systemic treatment options and the safety of resection and ablation, liver resection or RFA may be considered in selected patients with ACC metastatic to the liver especially with a long DFI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1245/s10434-011-1564-z

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

Sorted by citations

See all 62

Metadata

Authors
Ripley, R. T., Kemp, C. D., Davis, J. L., Langan, R. C., Royal, R. E., Libutti, S. K., Steinberg, S. M., Wood, B. J., Kammula, U. S., Fojo, T., & Avital, I.
Affiliations
National Institutes of Health (US)
Corresponding author
Ripley, R. Taylor
Venue
Annals of Surgical Oncology
Published
2011-02-08
Volume
18
Issue
7
Pages
1972-1979
ISSN
  • 1068-9265 (ISSN-L)
  • 1534-4681
OpenAlex
W2035711343
Cited by
62
References
20
Citations by year
2026: 1 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 6 · 2012: 3
FWCI
4.91
Type
journal article
Language
en
Open access
Locations
  • Annals of Surgical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (ZIABC011003, ZIABC010626, ZIDBC011242)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
adrenocortical carcinoma, liver metastasis, hepatectomy, radiofrequency ablation, extrahepatic disease, disease-free interval, overall survival, synchronous metastases
MeSH terms
Adolescent, Adrenal Cortex Neoplasms, Adult, Aged, Child, Combined Modality Therapy, Female, Follow-Up Studies, Hepatectomy, Humans, Liver Neoplasms, Male, Middle Aged, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate, Catheter Ablation, Adrenocortical Carcinoma, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma. https://app.cochat.ai/papers/10.1245/s10434-011-1564-z
The paper
Ripley, R. T., Kemp, C. D., Davis, J. L., Langan, R. C., Royal, R. E., Libutti, S. K., Steinberg, S. M., Wood, B. J., Kammula, U. S., Fojo, T., & Avital, I. (2011). Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-011-1564-z